Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
Jorge Santos da Silva

Jorge Santos da Silva

Co-founder and Chief Executive Officer, MoonLake Immunotherapeutics

Appears in 1 story

Notable Quotes

The company said the results support a potential best-in-class profile for the drug.

Stories

MoonLake pushes sonelokimab toward FDA approval for a painful skin disease

New Capabilities

Leading the company's first push for FDA approval

Hidradenitis suppurativa causes painful, recurring abscesses in the skin folds of about 1 in 100 people. For most of the past decade, one drug controlled it well enough to win U.S. approval. MoonLake now wants to change that.

Updated Yesterday